Cerrito, M. G., De Giorgi, M., Pelizzoni, D., Bonomo, S. M., Digiacomo, N., Scagliotti, A., . . . Cazzaniga, M. E. (2018). Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study. Oncotarget.
Citação norma ChicagoCerrito, Maria Grazia, et al. "Metronomic Combination of Vinorelbine and 5Fluorouracil Is Able to Inhibit Triple-negative Breast Cancer Cells. Results From the Proof-of-concept VICTOR-0 Study." Oncotarget 2018.
MLA CitationCerrito, Maria Grazia, et al. "Metronomic Combination of Vinorelbine and 5Fluorouracil Is Able to Inhibit Triple-negative Breast Cancer Cells. Results From the Proof-of-concept VICTOR-0 Study." Oncotarget 2018.